A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Tata India Pharma & HealthCare Fund
Regular
Direct
3 Year Absolute Returns
75.83% ↑
NAV (₹) on 02 Apr 2026
27.91
1 Day NAV Change
-0.71%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum SIP of ₹100 or ... Read more
NAV History
Fund Details
Min. SIP Amount
₹150
Inception Date
04 Dec 2015
Min. Lumpsum Amount
₹ 5,000
Fund Age
10 Yrs
AUM
₹ 1,300.81 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
2.11%
Scheme Type
Open Ended
Exit Load
0.25%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,300.81 Cr
Equity
188.39%
Money Market & Cash
11.61%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 58.69% |
| Hospitals & Medical Services | 35.52% |
| Agro Chemicals/Pesticides | 3.33% |
| Cash | 2.24% |
| CBLO/Reverse Repo | 0.20% |
| Medical Equipment & Accessories | 0.02% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 9.66% | ₹ 125.61 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD. | 6.78% | ₹ 88.23 | Hospitals & Medical Services |
| DIVI LABORATORIES LTD. | 5.94% | ₹ 77.29 | Pharmaceuticals |
| ABBOTT INDIA LTD. | 5.60% | ₹ 72.83 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD. | 5.04% | ₹ 65.61 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.00% | ₹ 65.04 | Hospitals & Medical Services |
| CIPLA LTD. | 4.55% | ₹ 59.16 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD. | 3.83% | ₹ 49.84 | Hospitals & Medical Services |
| MANKIND PHARMA LTD | 3.40% | ₹ 44.27 | Pharmaceuticals |
| BAYER CROPSCIENCE LTD. | 3.33% | ₹ 43.37 | Agro Chemicals/Pesticides |
| FORTIS HEALTHCARE LTD. | 3.27% | ₹ 42.56 | Hospitals & Medical Services |
| SAI LIFE SCIENCES LTD | 3.25% | ₹ 42.33 | Pharmaceuticals |
| J.B.CHEMICALS & PHARMACEUTICALS LTD. | 3.21% | ₹ 41.71 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD. | 3.13% | ₹ 40.68 | Hospitals & Medical Services |
| LUPIN LTD. | 3.08% | ₹ 40.11 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 3.04% | ₹ 39.60 | Pharmaceuticals |
| DR. LAL PATH LABS LTD. | 2.71% | ₹ 35.28 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD. | 2.64% | ₹ 34.36 | Hospitals & Medical Services |
| SYNGENE INTERNATIONAL LTD. | 2.39% | ₹ 31.15 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 2.24% | ₹ 28.68 | Others |
| ALKEM LABORATORIES LTD. | 2.15% | ₹ 28.01 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 2.06% | ₹ 26.77 | Pharmaceuticals |
| NEULAND LABORATORIES LTD. | 2.00% | ₹ 25.99 | Pharmaceuticals |
| SANOFI INDIA LTD. | 1.99% | ₹ 25.88 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 1.82% | ₹ 23.72 | Pharmaceuticals |
| FDC LTD. | 1.82% | ₹ 23.64 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD. | 1.55% | ₹ 20.17 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD. | 1.50% | ₹ 19.57 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD. | 1.07% | ₹ 13.90 | Pharmaceuticals |
| CORONA REMEDIES LTD | 0.99% | ₹ 12.93 | Pharmaceuticals |
| HIKAL LTD. | 0.60% | ₹ 7.75 | Pharmaceuticals |
| REPO | 0.20% | ₹ 2.61 | Others |
| DR. AGARWALS HEALTH CARE LTD. | 0.07% | ₹ 0.91 | Hospitals & Medical Services |
| JUBILANT PHARMOVA LTD | 0.07% | ₹ 0.93 | Pharmaceuticals |
| LAXMI DENTAL LIMITED | 0.02% | ₹ 0.28 | Medical Equipment & Accessories |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -7.44% | -2.03% | 5.05% | 20.70% |
| Category returns | -7.38% | 1.10% | 4.40% | 20.04% |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
AMC Details
Name
Tata Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Prathit Bhobe
CIO
Mr. Rahul Singh
Type
Pvt.Sector-Indian
Address
1903, B-Wing, Parinee Crescenzo,
G-Block, Bandra Kurla Complex,
Bandra East, Mumbai, Maharashtra, India - 400051
Website
http://www.tatamutualfund.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹183.63 | -6.78% | 32.14% | 68.18% | ₹4,273 | 1.92% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
DSP Quant Fund - Direct Plan
Largecap
Direct
|
₹20.71 | -0.11% | 31.80% | 44.78% | ₹838 | 0.55% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹31.33 | -7.57% | 31.57% | 70.85% | ₹2,300 | 2.06% |
Very High
|
Top Funds from Tata Asset Management Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata Nifty 50 Index Fund - Regular Plan
Index
Regular
|
₹141.23 | -2.16% | 32.81% | 56.93% | ₹1,514 | 0.51% |
Very High
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan - Growth
Hybrid
Regular
|
₹56.36 | 6.88% | 32.55% | 47.04% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹455.94 | -1.21% | 32.00% | 61.74% | ₹4,024 | 0.97% |
Very High
|
|
Tata Large & Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹508.48 | -8.92% | 31.96% | 65.37% | ₹8,143 | 0.72% |
Very High
|
|
Tata Large & Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹99.63 | -8.92% | 31.96% | 65.44% | ₹8,143 | 0.72% |
Very High
|
|
Tata Large & Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹99.63 | -8.92% | 31.96% | 65.44% | ₹8,143 | 0.72% |
Very High
|
|
Tata Housing Opportunities Fund
Sector
Regular
|
₹12.87 | -5.83% | 30.60% | 0.00% | ₹502 | 2.39% |
Very High
|
|
Tata Housing Opportunities Fund
Sector
Regular
|
₹12.87 | -5.83% | 30.60% | 0.00% | ₹502 | 2.39% |
Very High
|
FAQs
What is the current NAV of Tata India Pharma & HealthCare Fund Regular Growth?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund Regular Growth is ₹27.91 as of 02 Apr 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund Regular Growth?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund Regular Growth is ₹1,300.81 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund Regular Growth?
Tata India Pharma & HealthCare Fund Regular Growth has delivered returns of -2.03% (1 Year), 20.70% (3 Year), 13.52% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund Regular Growth?
Tata India Pharma & HealthCare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund Regular Growth?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund Regular Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
ఫిక్స్డ్ డిపాజిట్ (Fixed deposit) .. మ్యూచువల్ ఫండ్స్.. 10 ఏళ్లలో మీ డబ్బు ఎక్కడ డబుల్ అవుతుంది? -
Ugadi 2026: ఉగాది రోజున ఈ ఒక్క పని చేస్తే మీ దరిద్రం పోయి ఐశ్వర్యం వస్తుంది! -
Defence Stocks: రక్షణ రంగంలో పెట్టుబడులు పెడితే లాభమేనా? డిఫెన్స్ ఫండ్లపై నిపుణులు ఏమంటున్నారు? -
1 Crore: 10 ఏళ్లలో రూ. 1 కోటి..! రిస్క్ లేకుండా కోటీశ్వరులు అయ్యే ప్లాన్ ఇదే! -
SIP investment: రీల్స్ చూసి ఇన్వెస్ట్ చేస్తున్నారా? ఈ పొరపాట్లు చేస్తే మీ డబ్బులు గల్లంతే! -
EMI ట్రాప్లో పడకుండా ఐఫోన్ కొనడం ఎలా? నిపుణుల బెస్ట్ టిప్స్! -
డబ్బు కావలిసినంత ఉన్నా పర్సనల్ లోన్ల వైపు పరిగెత్తుతున్న ధనవంతులు.. కారణం ఏంటంటే.. -
Gold Silver: బంగారం, వెండి కలిపి కొనొచ్చు! ఈ సరికొత్త మ్యూచువల్ ఫండ్ ప్లాన్ మీ కోసమే! -
Mutual funds: మార్కెట్ ఒడిదుడుకులకు భయపడుతున్నారా? రాధికా గుప్తా చెప్పిన ఈ సింపుల్ ట్రిక్ పాటించండి! -
Mutual funds: రిటర్న్స్ కాదు, ఆదాయం గురించి ఆలోచించండి! అసలు మీ పోర్ట్ఫోలియో ఎలా ఉండాలంటే..
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+